Originally posted in MedPage Today by Todd Neale, MedPage Today Staff Writer Sanofi Pasteur has recalled about 800,000 pediatric doses of its vaccine against pandemic H1N1 influenza because of low potency, the CDC announced, but the agency is not calling for revaccinations. The recalled doses come from four lots of 0.25-mL prefilled syringes for pediatric use in both 10-packs (lot numbers UT023DA, ...

Read more...

Originally published in Insidermedicine The alarming risk of death associated with the use of prescribed narcotic drugs, particularly OxyContin, is highlighted in a study published in the latest issue of the Canadian Medical Association Journal. id="play_continuous_flvs" classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" width="385" height="239" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=6,0,40,0">
Read more...

Originally published in Insidermedicine Repeated use of the club drug MDMA, which is known on the street as "ecstasy" increases the risk of the breathing disorder known as sleep apnea, according to research published in journal Neurology. id="play_continuous_flvs" classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" width="385" height="239" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=6,0,40,0">
Read more...

Originally published in MedPage Today by Todd Neale, MedPage Today Staff Writer As one of the two MedPage Today writers on full-time H1N1 duty since the beginning of the outbreak in April, I feel like I know the issues well enough to help clear up misconceptions when they come up in conversation. medpage-today1The other day, just such a situation presented itself. An ...

Read more...

Pharma, evidence, and trust

by David Rind, MD A number of the other blogs that have noted the existence of this blog seem to have "Pharma" in their titles in one way or another, and the implication is not that the blogger likes much about Big Pharma. In the late 1990s, when I was spending much of my clinical time providing HIV care, I was a defender of Pharma on Usenet, at least as it related ...

Read more...

Originally published in Insidermedicine Three distinct types of drugs that affect mental processes can increase the risk of falling when taken by adults over 60, according to research published in the latest edition of the Archives of Internal Medicine. id="play_continuous_flvs" classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" width="385" height="239" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=6,0,40,0">
Read more...

Originally posted in Insidermedicine Identification and treatment of individuals with high LDL or "bad" cholesterol has improved in recent years, but patients are still slipping through the cracks, according to a survey published in the Journal of the American Medical Association. id="play_continuous_flvs" classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" width="385" height="239" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=6,0,40,0">
Read more...

My position on the H1N1 flu vaccine is clear: everyone should get it. But not every physician shares that sentiment. The Washington Post reports that there are a minority who are unconvinced of the vaccine's safety and believe the H1N1 pandemic is over-hyped. Worse, they aren't vaccinating their patients. And when you're talking about pediatricians, that can mean trouble for their patients; children who are most susceptible to the ...

Read more...

Originally published in MedPage Today by Peggy Peck, MedPage Today Executive Editor By a margin of 0.014 mm in carotid intima-media thickness (CIMT), extended-release niacin (Niaspan) demonstrated superiority over ezetimibe (Zetia) as an add-on for high risk patients on long term statin therapy. But is a difference of 0.014 mm clinically significant? The niacin versus ezetimibe findings come from the ARBITER 6-HALTS trial, ...

Read more...

Originally published in MedPage Today by Emily P. Walker, MedPage Today Washington Correspondent Drug and device makers are urging the FDA to establish clear guidelines that will allow the industry to discuss and promote products in the unsettled world of online social media. The FDA is hearing testimony from drug and device companies, online marketing experts, and consumer groups about what steps the ...

Read more...

Most Popular

✓ Join 150,000+ subscribers
✓ Get KevinMD's most popular stories